Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vor Bio to Participate in Upcoming Investor Conferences By: Vor Biopharma via GlobeNewswire August 28, 2024 at 08:00 AM EDT CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference1x1 Investor Meetings: Friday, September 6, 2024Location: New York, NY Baird 2024 Global Healthcare Conference Fireside Chat: Wednesday, September 11, 2024, at 7:55am ETLocation: New York, NY Chardan’s 8th Annual Genetic Medicines Conference Fireside Chat: Monday, September 30, 2024, at 4:30pm ETLocation: New York, NY About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Vor Bio to Participate in Upcoming Investor Conferences By: Vor Biopharma via GlobeNewswire August 28, 2024 at 08:00 AM EDT CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference1x1 Investor Meetings: Friday, September 6, 2024Location: New York, NY Baird 2024 Global Healthcare Conference Fireside Chat: Wednesday, September 11, 2024, at 7:55am ETLocation: New York, NY Chardan’s 8th Annual Genetic Medicines Conference Fireside Chat: Monday, September 30, 2024, at 4:30pm ETLocation: New York, NY About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference1x1 Investor Meetings: Friday, September 6, 2024Location: New York, NY Baird 2024 Global Healthcare Conference Fireside Chat: Wednesday, September 11, 2024, at 7:55am ETLocation: New York, NY Chardan’s 8th Annual Genetic Medicines Conference Fireside Chat: Monday, September 30, 2024, at 4:30pm ETLocation: New York, NY About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com. Contact: Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
